Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Company Research
  3. SP Angel Healthcare Conditions

SP Angel Healthcare Conditions

Mon, 16th Mar 2026 11:12

Cardiogeni plc (AQSE: CGNI)*: Loan funding of up to $25m for Phase IIb trialAvacta Therapeutics plc (AIM: AVCT): Opening of Phase I trial for AVA6103

Sign in to read this article

Login
Recently viewed
SAV
Savannah Resources
LSE
2.90%
UANC
UANC.L
LSE
0.00%
EDR
EDR.L
LSE
0.00%
HBRN
HBRN.L
LSE
0.00%
EKF
Ekf Diagnostics
LSE
-0.38%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
-20.00%
ITM
Itm Power
LSE
-4.99%
RRR
Red Rock Resources
LSE
15.91%
MKA
Mkango Resources
LSE
-4.52%
QHE
Quantum Helium
LSE
-6.54%